Ion channels in pain transmission

International Anesthesiology Clinics

Volumn 45, Issue 2, 2007, Pages 107-120

  Xie, Wenrui ^a,b  

^a UNIVERSITY OF CINCINNATI   (United States)

^b UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (N ETHYL N PHENYLAMINO) 1,2 DIMETHYL 6 (METHYLAMINO)PYRIMIDINIUM CHLORIDE; ALCOHOL; ANTISENSE OLIGONUCLEOTIDE; BACLOFEN; CLONIDINE; GABAPENTIN; MORPHINE; NICOTINE; OMEGA CONOTOXIN; OMEGA CONOTOXIN MVIIA; OXOTREMORINE; PROSTAGLANDIN SYNTHASE INHIBITOR; PROTEIN; PROTEIN ASIC; PURINE P2X RECEPTOR; PURINE P2X1 RECEPTOR; PURINE P2X2 RECEPTOR; PURINE P2X3 RECEPTOR; PURINE P2X4 RECEPTOR; PURINE P2X5 RECEPTOR; PURINE P2X6 RECEPTOR; PURINE P2X7 RECEPTOR; TRANSIENT RECEPTOR POTENTIAL CHANNEL; TREK 1 CHANNEL; UNCLASSIFIED DRUG; UNINDEXED DRUG; VANILLOID RECEPTOR 1; VOLTAGE GATED CALCIUM CHANNEL; VOLTAGE GATED POTASSIUM CHANNEL; VOLTAGE GATED SODIUM CHANNEL;

ALLODYNIA; ANALGESIC ACTIVITY; CAENORHABDITIS ELEGANS; CHRONIC PAIN; DROSOPHILA; DRUG MEGADOSE; ERYTHROMELALGIA; EXPERIMENTAL MOUSE; EXPERIMENTAL RAT; HUMAN; HYPERALGESIA; LOW DRUG DOSE; MAMMAL; NERVE CELL EXCITABILITY; NEUROCHEMISTRY; NEUROPATHIC PAIN; NEUROPATHOLOGY; NEUROTRANSMISSION; NOCICEPTION; NONHUMAN; PERIPHERAL NERVE INJURY; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; REVIEW;

ANIMALS; CALCIUM CHANNELS; CENTRAL NERVOUS SYSTEM; HUMANS; ION CHANNELS; PAIN; POTASSIUM CHANNELS; POTASSIUM CHANNELS, TANDEM PORE DOMAIN; RECEPTORS, PURINERGIC P2; SODIUM CHANNELS; SYNAPTIC TRANSMISSION; TRANSIENT RECEPTOR POTENTIAL CHANNELS;

EID: 34247195609     PISSN: 00205907     EISSN: None     Source Type: Journal    
DOI: 10.1097/AIA.0b013e31803419e7     Document Type: Review

References (54)

1. Clapham DE. TRP channels as cellular sensors. Nature. 2003;426:517-524.
2. Montell C, Birnbaumer L, Flockerzi V. The TRP channels, a remarkably functional family. Cell. 2002;108:595-598.
3. Caterina MJ, Leffler A, Malmberg AB, et al. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science. 2000;288:306-313.
4. Numazaki M, Tominaga M. Nociception and TRP channels. Curr Drug Targets CNS Neurol Disord. 2004;3:479-485.
5. Alessandri-Haber N, Yeh JJ, Boyd AE, et al. Hypotonicity induces TRPV4-mediated nociception in rat. Neuron. 2003;39:497-511.
6. Alessandri-Haber N, Dina OA, Yeh JJ, et al. Transient receptor potential vanilloid 4 is essential in chemotherapy-induced neuropathic pain in the rat. J Neurosci. 2004;24:4444-4452.
7. Bautista DM, Jordt SE, Nikai T, et al. TRPA1 mediates the inflammatory actions of environmental irritants and proalgesic agents. Cell. 2006;124:1269-1282.
8. Dowd E, McQueen DS, Chessell IP, et al. P2X receptor-mediated excitation of nociceptive afferents in the normal and arthritic rat knee joint. Br J Pharmacol. 1998;125:341-346.
9. Tsuda M, Koizumi S, Kita A, et al. Mechanical allodynia caused by intraplantar injection of P2X receptor agonist in rats: involvement of heteromeric P2X2/3 receptor signaling in capsaicin-insensitive primary afferent neurons. J Neurosci. 2000;20:RC90.
10. Park W, Masuda I, Cardenal-Escarcena A, et al. Inorganic pyrophosphate generation from adenosine triphosphate by cell-free human synovial fluid. J Rheumatol. 1996;23:665-671.
11. Sawynok J, Reid A. Peripheral adenosine 50-triphosphate enhances nociception in the formalin test via activation of a purinergic p2X receptor. Eur J Pharmacol. 1997;330:115-121.
12. Xu GY, Huang LY. Peripheral inflammation sensitizes P2X receptor-mediated responses in rat dorsal root ganglion neurons. J Neurosci. 2002;22:93-102.
13. McGaraughty S, Wismer CT, Zhu CZ, et al. Effects of A-317491, a novel and selective P2X3/P2X2/3 receptor antagonist, on neuropathic, inflammatory and chemogenic nociception following intrathecal and intraplantar administration. Br J Pharmacol. 2003;140:1381-1388.
14. Cockayne DA, Hamilton SG, Zhu QM, et al. Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice. Nature. 2000;407:1011-1015.
15. Tsuzuki K, Kondo E, Fukuoka T, et al. Differential regulation of P2X(3) mRNA expression by peripheral nerve injury in intact and injured neurons in the rat sensory ganglia. Pain. 2001;91:351-360.
16. Zhou JL, Chung KS, Chung JM. Development of purinergic sensitivity in sensory neurons after peripheral nerve injury in the rat. Brain Res. 2001;915:161-169.
17. Sluka KA, Price MP, Breese NM, et al. Chronic hyperalgesia induced by repeated acid injections in muscle is abolished by the loss of ASIC3, but not ASIC1. Pain. 2003;106:229-239.
18. Alloui A, Zimmermann K, Mamet J, et al. TREK-1, a K(+ ) channel involved in polymodal pain perception. Embo J. 2006;25:2368-2376.
19. Hong S, Morrow TJ, Paulson PE, et al. Early painful diabetic neuropathy is associated with differential changes in tetrodotoxin-sensitive and -resistant sodium channels in dorsal root ganglion neurons in the rat. J Biol Chem. 2004;279:29341-29350.
20. Lindia JA, Kohler MG, Martin WJ, et al. Relationship between sodium channel NaV1.3 expression and neuropathic pain behavior in rats. Pain. 2005;117:145-153.
21. Black JA, Cummins TR, Plumpton C, et al. Upregulation of a silent sodium channel after peripheral, but not central, nerve injury in DRG neurons. J Neurophysiol. 1999;82:2776-2785.
22. Boucher TJ, Okuse K, Bennett DL, et al. Potent analgesic effects of GDNF in neuropathic pain states. Science. 2000;290:124-127.
23. Michiels JJ, te Morsche RH, Jansen JB, et al. Autosomal dominant erythermalgia associated with a novel mutation in the voltage-gated sodium channel alpha subunit Nav1.7. Arch Neurol. 2005;62:1587-1590.
24. Gould HJ III, England JD, Soignier RD, et al. Ibuprofen blocks changes in Na v 1.7 and 1.8 sodium channels associated with complete Freund's adjuvant-induced inflammation in rat. J Pain. 2004;5:270-280.
25. Nassar MA, Stirling LC, Forlani G, et al. Nociceptor-specific gene deletion reveals a major role for Nav1.7 (PN1) in acute and inflammatory pain. Proc Natl Acad Sci U S A. 2004;101:12706-12711.
26. Cox JJ, Reimann F, Nicholas AK, et al. An SCN9A channelopathy causes congenital inability to experience pain. Nature. 2006;444:894-898.
27. Kral MG, Xiong Z, Study RE. Alteration of Na+ currents in dorsal root ganglion neurons from rats with a painful neuropathy. Pain. 1999;81:15-24.
28. Gold MS, Weinreich D, Kim CS, et al. Redistribution of Na(V)1.8 in uninjured axons enables neuropathic pain. J Neurosci. 2003;23:158-166.
29. Roza C, Laird JM, Souslova V, et al. The tetrodotoxin-resistant Na+ channel Nav1.8 is essential for the expression of spontaneous activity in damaged sensory axons of mice. J Physiol. 2003;550:921-926.
30. Laird JM, Souslova V, Wood JN, et al. Deficits in visceral pain and referred hyperalgesia in Nav1.8 (SNS/PN3)-null mice. J Neurosci. 2002;22:8352-8356.
31. England S, Bevan S, Docherty RJ. PGE2 modulates the tetrodotoxin- resistant sodium current in neonatal rat dorsal root ganglion neurones via the cyclic AMP-protein kinase A cascade. J Physiol (Lond). 1996;495:429-440.
32. Cardenas CG, Delmar LP, Cooper BY, et al. 5ht(4) receptors couple positively to tetrodotoxin-insensitive sodium channels in a subpopulation of capsaicin-sensitive rat sensory neurons. J Neurosci. 1997;17:7181-7189.
33. Gold MS, Reichling DB, Shuster MJ, et al. Hyperalgesic agents increase a tetrodotoxin-resistant Na+ current in nociceptors. Proc Natl Acad Sci U S A. 1996;93:1108-1112.
34. Khasar SG, McCarter G, Levine JD. Epinephrine produces a beta-adrenergic receptor-mediated mechanical hyperalgesia and in vitro sensitization of rat nociceptors. J Neurophysiol. 1999;81:1104-1112.
35. Zhou Z, Davar G, Strichartz G. Endothelin-1 (ET-1) selectively enhances the activation gating of slowly inactivating tetrodotoxin-resistant sodium currents in rat sensory neurons: a mechanism for the pain-inducing actions of ET-1. J Neurosci. 2002;22:6325-6330.
36. Zhang YH, Vasko MR, Nicol GD. Ceramide, a putative second messenger for nerve growth factor, modulates the TTX-resistant Na(+ ) current and delayed rectifier K(+ ) current in rat sensory neurons. J Physiol. 2002;544:385-402.
37. Dina OA, McCarter GC, de Coupade C, et al. Role of the sensory neuron cytoskeleton in second messenger signaling for inflammatory pain. Neuron. 2003;39:613-624.
38. Priest BT, Murphy BA, Lindia JA, et al. Contribution of the tetrodotoxin-resistant voltage-gated sodium channel NaV1.9 to sensory transmission and nociceptive behavior. Proc Natl Acad Sci U S A. 2005;102:9382-9387.
39. Govrin-Lippmann R, Devor M. Ongoing activity in severed nerves: source and variation with time. Brain Res. 1978;159:406-410.
40. Chaplan SR, Guo HQ, Lee DH, et al. Neuronal hyperpolarization-activated pacemaker channels drive neuropathic pain. J Neurosci. 2003;23:1169-1178.
41. CatterallWA, Striessnig J, Snutch TP, et al. International Union of Pharmacology. XL. Compendium of voltage-gated ion channels: calcium channels. Pharmacol Rev. 2003;55:579-581.
42. Matthews EA, Dickenson AH. Effects of spinally delivered N- and P-type voltagedependent calcium channel antagonists on dorsal horn neuronal responses in a rat model of neuropathy. Pain. 2001;92:235-246.
43. Luo ZD, Chaplan SR, Higuera ES, et al. Upregulation of dorsal root ganglion alpha(2)delta calcium channel subunit and its correlation with allodynia in spinal nerve-injured rats. J Neurosci. 2001;21:1868-1875.
44. 2+ channel. EMBO J. 2001;20:2349-2356.
45. Scott DA, Wright CE, Angus JA. Actions of intrathecal omega-conotoxins CVID, GVIA, MVIIA, and morphine in acute and neuropathic pain in the rat. Eur J Pharmacol. 2002;451:279-286.
46. Li CY, Song YH, Higuera ES, et al. Spinal dorsal horn calcium channel alpha2delta-1 subunit upregulation contributes to peripheral nerve injury-induced tactile allodynia. J Neurosci. 2004;24:8494-8499.
47. Yaksh TL. Calcium channels as therapeutic targets in neuropathic pain. J Pain. 2006;7:S13-S30.
48. Park SY, Choi JY, Kim RU, et al. Downregulation of voltage-gated potassium channel alpha gene expression by axotomy and neurotrophins in rat dorsal root ganglia. Mol Cells. 2003;16:256-259.
49. Hu HJ, Gereau RWT. ERK integrates PKA and PKC signaling in superficial dorsal horn neurons. II. Modulation of neuronal excitability. J Neurophysiol. 2003;90:1680-1688.
50. Hu HJ, Glauner KS, Gereau RWT. ERK integrates PKA and PKC signaling in superficial dorsal horn neurons. I. Modulation of A-type K+ currents. J Neurophysiol. 2003;90:1671-1679.
51. Watanabe S, Hoffman DA, Migliore M, et al. Dendritic K+ channels contribute to spike-timing dependent long-term potentiation in hippocampal pyramidal neurons. Proc Natl Acad Sci U S A. 2002;99:8366-8371.
52. Tatulian L, Delmas P, Abogadie FC, et al. Activation of expressed KCNQ potassium currents and native neuronal M-type potassium currents by the anti-convulsant drug retigabine. J Neurosci. 2001;21:5535-5545.
53. Blednov YA, Stoffel M, Alva H, et al. A pervasive mechanism for analgesia: activation of GIRK2 channels. Proc Natl Acad Sci U S A. 2003;100:277-282.
54. North RA. Twelfth Gaddum memorial lecture. Drug receptors and the inhibition of nerve cells. Br J Pharmacol. 1989;98:13-28.